Form 4 Tracker
Reshma Rangwala

EVP & Chief Medical Officer · 4 filings · Latest: May 13, 2026

Karyopharm Therapeutics Inc.
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
KPTI
Reshma RangwalaEVP & Chief Medical OfficerMay 14, 2026
Sale
$9.50408$3.9K56,829
KPTI
Reshma RangwalaEVP & Chief Medical OfficerApr 21, 2026
Sale
$8.94449$4.0K56,290
KPTI
Reshma RangwalaEVP & Chief Medical OfficerMar 2, 2026
Sale
$9.415,066$47.7K56,739